The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
Welcome to The Follicular Lymphoma (FL) Channel
VJHemOnc is excited to introduce The Follicular Lymphoma (FL) Channel, providing you the latest in follicular lymphoma presented at major international congresses by world-renowned experts. Keep updated in the field with exclusive video interviews, podcasts and roundtable discussions.
In addition to perspectives in promising treatments including CAR-T and epigenetic therapeutics, The Follicular Lymphoma Channel covers exciting clinical trial data, current management strategies, and discussion of unmet needs within FL.
The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
Diamond Supporter
Gold Supporter
Silver Supporter
Bronze Supporter
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
If you are interested in becoming a supporter of The Lymphoma Channel, please contact us.
